Regulatory Insights

  1. ICH E6(R3) Annex 2: Navigating GCP Requirements For Decentralized Trials 7/24/2026

    Implementing decentralized components or real-world data requires proactive alignment with updated GCP standards for data access, remote consent, and multi-stream investigator oversight.

  2. The Evolution Of GLP-1s: Overcoming Clinical Development Challenges 7/23/2026

    Explore clinical development trends, recruitment hurdles, study design strategies, and emerging therapies shaping obesity and metabolic disease research.

  3. Five Preventable Clinical Design Pitfalls And How To Avoid Them 7/21/2026

    While late-stage trial attrition is often attributed to inadequate safety or efficacy, the true failure may be insufficient upstream planning and/or misalignment between clinical and commercial goals.

  4. Strategic Implications Of The Single Phase 3 Approval Paradigm 7/21/2026

    As FDA single-trial approvals gain traction, CNS developers need stronger early evidence. Learn how biomarkers, patient selection, and regulatory strategy can accelerate development.

  5. Unifying Research - HRPP Vs IRB And Participant Christine 7/21/2026

    HRPPs and IRBs play different but connected roles in protecting research participants. Hear expert guidance, firsthand experiences, and questions that can help people make more informed decisions.

  6. Unifying Research - Research Administration And Participant Caregiver 7/21/2026

    Go behind the scenes of cancer clinical trials operations and hear a caregiver’s perspective on supporting a research participant, including the challenges, needs, and opportunities.

  7. Unifying Research - Research Compliance And Patient Stephanie 7/21/2026

    A research compliance leader and a patient advocate explore how ethical oversight, privacy, and the IRB intersect while sharing a personal PMDD journey that shows the potential of participation.

  8. At The Turning Point – Shaping The Future Of Hematology 7/20/2026

    Hematology is at a turning point. Turn complexity into strategy with smarter trial design, stronger patient engagement, confident regulatory navigation and real-world evidence insights.

  9. Translating R3 Data Governance And Oversight Into Practice 7/18/2026

    Learn how to translate ICH E6(R3) into practice with actionable strategies for proactive risk management, robust data governance, and earlier deviation detection.

  10. From Chaos To Clarity: A Founder's View From 30 Years In Drug Development 7/16/2026

    Same workflows, higher stakes. A 30-year drug development veteran reveals how outdated sample handling puts trial outcomes at risk and what sponsors can do about it.